Popular Articles
Teeth Whitening

Shire Presented Results Of A New Database Analysis On Lialda(R) (Mesalamine) And Other 5-ASAs For Ulcerative Colitis At Digestive Disease Week
Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, presented the results of a 5-aminosalicylic acid (5-ASA) persistency analysis entitled, "Twelve-month Persistence with 5-aminosalicylic Acid Therapy: Results from a Large Pharmacy Database," at Digestive Disease Week, on May 31, 2009. Results showed that after 12 months of therapy for continuing patients, 20 percent of Lialda patients were continually persistent, 9 percent of Asacol(R) (mesalamine) patients, 7 percent (250mg) and 10 percent (500mg) of Pentasa(R) (mesalamine) patients, 10 percent of balsalazide [combined results from generic balsalazide disodium and Colazal(R) (balsalazide disodium)] patients, and 10 percent (500mg) of Dipentum(R) (olsalazine sodium) patients were persistent. Continually persistent patients were defined as those who refilled their prescription within a period of up to twice the duration of the prescription that preceded the refill. Lialda is an FDA-approved, once-daily oral medication for the induction of remission in patients with active, mild to moderate ulcerative colitis (UC). Safety and effectiveness of Lialda beyond eight weeks have not been established.
generic viagra online
Change4Life Corner Shops To Open Across The Country, UK
Corner shops nationwide will get help from Change4Life to sell fruit and veg - this will mean more people will get their 5 a day and shops will see an increase in profits, Secretary of State for Health Andy Burnham said today.
News of the day
How Oxidative Stress May Help Prolong Life
Oxidative stress has been linked to aging, cancer and other diseases in
Medical Devices

Two Doctors Share Their Expectations For Health Reform

Two doctors with over 30 years of experience spoke with National Public Radio about how medicine has changed over their careers, and what they expect to see come out of the current health reform debate. Dr. Greg Darrow, a family physician from New Mexico who favors a single-payer system, said the demands of the business-side of his group practice often interfere with the quality of his care. "Leave me alone, I know what I do best, which is to take good care of people," Darrow said. Sometimes, patients interfere, too, by demanding care they may not need, a pattern he blames on direct marketing by pharmaceutical companies and newly available technologies. In one scenario, Darrow envisions himself recommending ice for a patient"s twisted knee, while the patient requests an MRI. Dr. George Knaysi, a cancer surgeon from Virginia, says he believes "most people feel health care is a right, not a privilege," but that the prospects of rationing in health reform make him uncomfortable with some reform proposals. He anticipates the creation of a government-run insurance plan, but adds, "I think there are too many people in this country who are middle class and upper-middle class who are not going to be willing to sit through long waiting lines." Rising costs - which Knaysi says haven"t kept pace with reimbursements - will eventually force the American health system to squeeze administrative costs and limit care options to remain sustainable. However, he anticipates a balancing act to accommodate patients who want to pay out of pocket for the most expensive treatments (Block, 6/30). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):